Mark LaPack is a consultant with more than 30 years experience working in the pharmaceutical and specialty chemical industry, leading the design, transfer, and validation of commercial manufacturing processes. He works with research and manufacturing organizations in North America, Europe, and Asia to help pharmaceutical companies bring new medicines to patients. To aid the regulatory approval of these medicines, he is writing chemical, manufacturing, and controls sections for regulatory submission documents. Mark’s career experiences include senior scientist and management positions at The Dow Chemical Company, GD Searle, Pharmacia, and Eli Lilly.